PrEP dispensing with HIV self-testing.

Lancet HIV

Africa Health Research Institute, Mtubatuba, KwaZulu-Natal, South Africa; Institute for Global Health, University College London, London, UK; University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Published: July 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(22)00171-0DOI Listing

Publication Analysis

Top Keywords

prep dispensing
4
dispensing hiv
4
hiv self-testing
4
prep
1
hiv
1
self-testing
1

Similar Publications

Article Synopsis
  • Doxycycline postexposure prophylaxis (doxyPEP) effectively reduces the incidence of bacterial sexually transmitted infections (STIs) in those assigned male at birth, although practical data is limited.
  • This study analyzed electronic health records of HIV PrEP users from Kaiser Permanente Northern California to assess the uptake of doxyPEP and its impact on STI rates before and after its initiation.
  • Out of 11,551 HIV PrEP users, 19.5% received doxyPEP, with a notable percentage having an STI prior; findings suggest changes in STI positivity rates among those who started doxyPEP versus those who did not.
View Article and Find Full Text PDF

The goal of this study was to evaluate characteristics associated with Pre-exposure Prophylaxis for HIV infection (PrEP) non-adherence or discontinuation in Brazil and assess the association between these outcomes and HIV seroconversion. We used linked national dispensing and pathology data to identify people aged 14+ years initiating PrEP in 2018. We estimated non-adherence using the proportion of days covered (PDC), defining non-adherence as PDC < 60%.

View Article and Find Full Text PDF

Objective: To describe the sociodemographic and clinical follow-up profile of the use of pre-exposure prophylaxis (PrEP) of HIV among transgender people receiving care at a reference health service for sexually transmitted infections and HIV/AIDS in São Paulo, the capital city of São Paulo state, between 2018 and 2021.

Method: This was a descriptive study with an analysis of sociodemographic data, reasons for seeking PrEP , discontinuation of use and experiences of clinical follow-up. Descriptive statistics were used.

View Article and Find Full Text PDF

Background: Despite high oral pre-exposure prophylaxis (PrEP) uptake among young heterosexual cisgender women, early discontinuation is frequent. It is unclear whether this aligns with potential HIV exposure.

Methods: Young women 16-25 years and ≥1 of their male partners were enrolled in separate but linked longitudinal HIV PrEP studies in Kampala, Uganda from 2018-2021.

View Article and Find Full Text PDF
Article Synopsis
  • Pregnant and breastfeeding women in sub-Saharan Africa, particularly Zambia, are at high risk for HIV and could greatly benefit from pre-exposure prophylaxis (PrEP) to reduce this risk.
  • A study involving 389 women assessed their preferences for various aspects of PrEP service delivery, including waiting times and provider attitudes, using a discrete choice experiment.
  • The findings indicated that women prioritize shorter waiting times and a 3-month supply of PrEP, even if it means enduring longer travel and less-than-friendly care, highlighting the importance of patient-centered service design.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!